by Jimmy Carter | Sep 11, 2018 | Alzheimer’s
It is well known that Alzheimer’s is a progressive disease, advancing through distinct stages of decline. Every individual will experience the disease differently, but the trajectory of the disease from the beginning to the end is often similar. On average, a person...
by Jimmy Carter | Sep 6, 2018 | Alzheimer’s
On August 23rd the U.S. Senate voted to pass the largest increase in history earmarked for Alzheimer’s Research. The increase of $425 million would go to Alzheimer’s and dementia research funding at the National Institutes of Health. This funding would bring the...
by Jimmy Carter | Sep 4, 2018 | Alzheimer’s
A recent research study conducted by the Harvard Medical School suggests that brain changes leading up to what is ultimately an Alzheimer’s diagnosis occur many years before onset of symptoms. Another of many important notes on the science of cognitive decline,...
by Jimmy Carter | Aug 30, 2018 | Dementia
One of the hallmarks of Alzheimer’s disease, and other dementia-related illness, is profound anxiety. In the context of clients who are challenging a will, or defending such a challenge, we sometimes see this anxiety appear in the decedent’s medical records. Whether...
by Jimmy Carter | Aug 28, 2018 | Dementia
We’ve discussed at length on this blog that dementia is on the rise. As a matter of fact, 47 million people worldwide are affected by dementia and by the year 2030 that number is expected to rise to 75 million. One other topic we’ve explored is the myriad of risk...
